Eugene C. Tarne

The state of Maryland is home to the Johns Hopkins University School of Medicine, one of the country’s leading stem cell research programs.   Maryland is also one of a handful of states to provide public funds for stem cell research, through

Soon after then-President Clinton’s National Bioethics Advisory Committee (NBAC) in 1999 issued a report recommending federal funding for human embryonic stem cell research (hESCR) the subject of such funding became one of the nation’s most hotly contested public policy issues. It was

The third and most recent round of grants awarded earlier this year for stem cell research by the state of Minnesota tracks a pattern established with the two earlier rounds of grants: a noticeable lack of support for human embryonic stem cell

Ever since human embryonic stem cells (hESCs) were first successfully grown in the lab in 1998, Parkinson’s Disease has featured prominently as one of the major diseases that such cells would supposedly eliminate.   

Proponents of assisted suicide often dismiss “slippery slope” arguments on the grounds that proper safeguards will assure that assisted suicide will not devolve into euthanasia, either voluntary or not. Earlier this year, for example, Hawaii became another of several states to consider

In 2013, the California Institute for Regenerative Medicine (CIRM) – the nation’s largest funder of stem cell research outside of the federal government – authorized a new program, the Alpha Stem Cell Clinics Network. The Network’s goal, according to CIRM, “is to

In 2014, Minnesota became the most recent of a handful of states that provide state funding for all types of stem cell research, including human embryonic stem cell research. The law provides for 10 years of funding with $4.5 million approved for

The Maryland Stem Cell Research Fund (MSCRF) has awarded two rounds of grants since the Charlotte Lozier Institute last analyzed the Fund’s pattern of grant making for stem cell research, in the fall of 2013. That study found that since MSCRF first

A recent press release from the National Institutes of Health calls attention to a study, published in Stem Cell Reports, that researchers have “developed a clinical-grade stem cell line, which has the potential to accelerate the advance of new medical applications and

One of the earliest attempts to square this circle of trying to conduct morally problematic research within ethical guidelines is the “14-day rule” for embryo research. The rule has allowed embryo research outside the womb for up to 14 days post-fertilization, after